{"id":"W3014809226","doi":"10.1007/s10549-020-05614-5","title":"Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"Cancer Care Ontario; Institute for Clinical Evaluative Sciences; Sunnybrook Hospital; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Ontario Institute for Cancer Research; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research","keywords":"Pertuzumab; Medicine; Trastuzumab; Cohort; Internal medicine; Metastatic breast cancer; Population; Breast cancer; Trastuzumab emtansine; Oncology; Randomized controlled trial; Cohort study; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002991298,0.0003841789,0.001065639,0.001032789,0.0004352885,0.00150299,0.0006861777,0.0009373445,0.002524703],"category_scores_gemma":[0.01159854,0.0002293081,0.002077604,0.00130338,0.0003854673,0.001206555,0.0009833932,0.0009766429,0.0002670942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007554153,"about_ca_system_score_gemma":0.0006691569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002395705,"about_ca_topic_score_gemma":0.002015841,"domain_scores_codex":[0.9970203,0.001071992,0.0003977026,0.0006674429,0.0003671813,0.0004754009],"domain_scores_gemma":[0.993966,0.001997826,0.002490659,0.0004375724,0.0004889159,0.0006190452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0215878,0.0002829415,0.9667608,0.0001086197,0.003856788,0.0002111998,0.000119466,0.0003687745,0.0006045079,0.000199637,0.0007390032,0.005160491],"study_design_scores_gemma":[0.0008939622,0.003536359,0.9918934,0.00002742041,0.001262603,0.0003664841,0.0003305009,0.0007023214,0.0001427481,0.0002705691,0.0005504244,0.00002316564],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969586,0.0007926444,0.0001803799,0.0001167432,0.00003094654,0.00003618963,0.001132262,0.000006067628,0.0007462801],"genre_scores_gemma":[0.9977418,0.0001851835,0.00005117941,0.00007864737,0.00003590715,0.00004167583,0.001692813,0.000004160418,0.0001684895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002991298,"threshold_uncertainty_score":0.01581973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2365462879418454,"score_gpt":0.5262910221048149,"score_spread":0.2897447341629695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}